Connect Conference & Show Floor Educational Sessions

View, browse and sort the list of Connect Conference sessions and show floor programming by pass type, track, and format. Please note, all Connect Conference delegates have access to CPhI Connect and InformEx Connect programming. Seating is first come, first serve, so please arrive early to sessions that you would like to attend. Sessions are subject to change.

To learn more about the Connect Conference program, click here.

All SessionsSpeakersMy Schedule
View Sessions As:
  • Ahmed ElsawahPresidentDPS Consulting

    Thirty seven years in the Pharmaceutical industry covering all of its diversified components with excellence in business development and in-licensing/out-licensing deal making. Ahmed Elsawah was an essential member in developing the kickoff of the pharmaceutical industry in Saudi Arabia through leading the business development activities of SPIMACO, and concluding milestone strategic alliances with major multinational companies like Pfizer, Roche, Glaxo, Novartis, Lilly, Merck, BMS and others. He participated in establishing the first multipurpose API manufacturing facility in the MENA Region CAD Middle East. The variety of models developed has enriched the outcomes of collaboration with partners which included second trade mark licensing, JVs, 3rd party promotion, divestment, and acquisition. His BD activities have included extensive interaction with major multinational consultancy firms like Mckinzey, ML, Bain and Co, BCG, Camelot, Ronald Berger, and others. He represented Spimaco as the majority shareholder in establishing the first multipurpose API manufacturing facility in the MENA region. Elsawah also had the opportunity of leading a specialized team to launch the first biotech breakthrough product, Eprex, for J&J in the Middle East from the late 80s to the early 90s. He also worked for Lundbeck as GM for Egypt and Saudi Arabia from 2002 to 2006, registering and launching its major antidepressant, Cipralex.